Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
申请公布号
WO2014123894(A1)
申请公布日期
2014.08.14
申请号
WO2014US14654
申请日期
2014.02.04
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
WANG, TAO;ZHANG, ZHONGXING;YIN, ZHIWEI;SUN, LI-QIANG;MULL, ERIC;ZHAO, QIAN;SCOLA, PAUL, MICHAEL